Cite
HARVARD Citation
Tate, C. et al. (2019). High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy. Leukemia & lymphoma. 60 (10), pp. 2563-2567. [Online].